Management of Chemotherapy-Ineligible AML: Beyond HMA Monotherapy - Episode 6

Practical Considerations for Venetoclax Plus HMA for Chemotherapy-Ineligible AML

Dr Stein elaborates on some practical considerations for the use of venetoclax and hypomethylating agents for the treatment of patients with chemotherapy-ineligible acute myeloid leukemia.